{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:49:16Z","timestamp":1740185356017,"version":"3.37.3"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clineuro.2025.108756","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T17:24:00Z","timestamp":1737912240000},"page":"108756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A prospective design is required to calculate the epidemiological parameters of patients with SARS-CoV-2-vaccination associated GBS"],"prefix":"10.1016","volume":"249","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2025.108756_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108183","article-title":"Guillain-Barr\u00e9 syndrome after COVID-19 vaccination: a systematic review and analysis of case reports","volume":"238","author":"Abuawwad","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"52","key":"10.1016\/j.clineuro.2025.108756_bib2","doi-asserted-by":"crossref","first-page":"9697","DOI":"10.1016\/j.vaccine.2011.09.123","article-title":"Guillain-Barr\u00e9 Syndrome in India: population-based validation of the Brighton criteria","volume":"29","author":"Mateen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.clineuro.2025.108756_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113008","article-title":"Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs","volume":"164","author":"Seneff","year":"2022","journal-title":"Food Chem. Toxicol."},{"issue":"22","key":"10.1016\/j.clineuro.2025.108756_bib4","doi-asserted-by":"crossref","first-page":"14222","DOI":"10.3390\/ijms232214222","article-title":"Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates","volume":"23","author":"Finsterer","year":"2022","journal-title":"Int J. Mol. Sci."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:13:54Z","timestamp":1740183234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":4,"alternative-id":["S0303846725000393"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108756","relation":{},"ISSN":["0303-8467"],"issn-type":[{"type":"print","value":"0303-8467"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective design is required to calculate the epidemiological parameters of patients with SARS-CoV-2-vaccination associated GBS","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.108756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108756"}}